Kunihiro Fushiki

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun
Shimonagakubo, 4118777, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Journal: International journal of clinical oncology
Published: July 09, 2026

Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.

Impact of prior nivolumab on treatment outcomes of taxane plus ramucirumab in advanced gastric cancer.

Journal: Japanese journal of clinical oncology
Published: February 20, 2026

Long-term follow-up of neoadjuvant chemotherapy in resectable human papillomavirus-associated oropharyngeal cancer.

Long-term follow-up of neoadjuvant chemotherapy in resectable human papillomavirus-associated oropharyngeal cancer.

Journal: International journal of clinical oncology
Published: January 13, 2026

Uptake of cascade tests in relatives of patients undergoing cancer precision medicine in Japan.

Uptake of cascade tests in relatives of patients undergoing cancer precision medicine in Japan.

Journal: Japanese journal of clinical oncology
Published: November 20, 2025

Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.

Journal: International journal of clinical oncology
Published: March 19, 2025

Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, noncomparative trial.

Optimal number of needle passes in endoscopic ultrasound-guided tissue sampling for genomic profiling: a randomized, noncomparative trial.

Journal: Gastrointestinal endoscopy
Published: January 24, 2025

A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.

A phase II study of ME2136 (Asenapine Maleate) plus standard antiemetic therapy for patients, including diabetic patients, receiving cisplatin-based chemotherapy.

Journal: Investigational new drugs
Published: August 14, 2024

Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer.

Lenvatinib rechallenge after failure of lenvatinib and sorafenib in metastatic thyroid cancer.

Journal: Investigational new drugs
Published: April 18, 2024

Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.

Impact of relative cisplatin dose to skeletal muscle mass on adverse events in patients with head and neck cancer undergoing chemoradiotherapy.

Journal: The oncologist
Published: March 25, 2024

Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age.

Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age.

Journal: Thoracic cancer
Published: March 13, 2024

Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia.

Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia.

Journal: BMC palliative care
Published: December 20, 2023

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin.

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin.

Journal: BMC cancer
Published: September 14, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026